Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

102.50 +1.59 (+1.58%)
Official Closing Price Updated: 4:10 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Ignore
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Electric Vehicles
A Look Into Boston Scientific Inc's Price Over Earnings
 
Via Benzinga
Boston Scientific Corp (NYSE:BSX) Shows Strong Growth and Bullish Technical Setup
Discover Boston Scientific (BSX), a top growth stock with strong earnings, revenue acceleration, and a bullish technical setup signaling a potential price surge. 
Via Chartmill
1 Safe-and-Steady Stock to Keep an Eye On and 2 We Question
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Boston Scientific To Acquire Privately-Held Pain Solutions Developer Nalu Medical For About $533M
Via Stocktwits
2 Large-Cap Stocks Worth Investigating and 1 That Underwhelm
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
5 Insightful Analyst Questions From Boston Scientific’s Q3 Earnings Call
Boston Scientific’s third quarter saw a positive market reaction, reflecting operational execution across multiple business units. Management attributed the strong results to broad-based growth,... 
Via StockStory
Topics Earnings
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
 
Via Benzinga
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares... 
Via MarketMinute
Topics Earnings Supply Chain
What the Options Market Tells Us About Boston Scientific
 
Via Benzinga
BSX Q3 Deep Dive: WATCHMAN and Electrophysiology Drive Outperformance, Guidance Raised
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q3 CY2025, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s revenue was... 
Via StockStory
Topics World Trade
These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings
 
Via Benzinga
Top S&P500 movers in Wednesday's session
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance. 
Via Benzinga
Tech Stocks Drop, Netflix Sinks 10% On Worst Day Since 2022: What's Moving Markets Wednesday?
Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence. 
Via Benzinga
Topics World Trade
Boston Scientific (BSX) Stock Is Up, What You Need To Know
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the company reported strong third-quarter results that topped Wall Street's forecasts and raised... 
Via StockStory
Topics Artificial Intelligence
Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growth
Boston Scientific Q3 revenue hit $5.07 billion, beating forecasts. The company raised its full-year guidance based on strong segment growth. 
Via Benzinga
Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market
Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Boston Scientific Jumps On Third-Quarter Beat, Strong Guide
Boston Scientific stock jumped early Wednesday on a strong 2025 outlook following its third-quarter sales and earnings beat. 
Via Investor's Business Daily
Boston Scientific Corp (NYSE:BSX) Reports Strong Q3 2025 Earnings, Beats Estimates
Boston Scientific beats Q3 2025 earnings and revenue forecasts, reporting strong sales growth and issuing optimistic Q4 guidance. 
Via Chartmill
Topics Earnings
Beware The Death Cross: 3 Stocks Triggering This Spooky Signal
The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal. 
Via MarketBeat
Topics ETFs
Boston Scientific’s (NYSE:BSX) Q3 Sales Top Estimates
Medical device company Boston Scientific (NYSE:BSX) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s... 
Via StockStory
What to Expect from Boston Scientific's Earnings
 
Via Benzinga
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company Boston Scientific (NYSE:BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For October 22, 2025
 
Via Benzinga
21 Analysts Have This To Say About Boston Scientific
 
Via Benzinga
Boston Scientific's Options: A Look at What the Big Money is Thinking
 
Via Benzinga
Boston Scientific To Acquire Nalu Medical In $600 Million Pain Relief Deal
Boston Scientific Corp (NYSE: BSX) to acquire Nalu Medical Inc. for $600 million in cash. Deal expected to close in first half of 2026. 
Via Benzinga
$1000 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.